Drug-induced lupus erythematosus in childhood: Case-based review.

Drug induced lupus children drug-induced systemic lupus erythematosus drug-related lupus

Journal

Lupus
ISSN: 1477-0962
Titre abrégé: Lupus
Pays: England
ID NLM: 9204265

Informations de publication

Date de publication:
05 Apr 2024
Historique:
medline: 6 4 2024
pubmed: 6 4 2024
entrez: 5 4 2024
Statut: aheadofprint

Résumé

Drug-induced lupus erythematosus (DILE) is the development of lupus-like syndrome following a drug exposure. DILE has been reported less frequently among children than adults. In this study, we present four children with DILE and similar published cases through a systematic literature review. We report four children (three girls and one boy) who developed DILE associated with the use of topiramate, doxycycline, etanercept, and ethosuximide. Three of them were positive for anti-histone antibodies. In all patients, the drug was discontinued and symptoms resolved completely. The literature review revealed 48 articles describing 61 children with DILE. In the evaluation of 65 patients (our 4 patients and 61 patients from the literature), the most frequently reported drugs associated with DILE were ethosuximide ( For children presenting with SLE features, proper drug history is crucial since DILE may be more frequent than anticipated. An association of the relevant drug with the symptoms, and resolution of symptoms on drug withdrawal provides evidence for the diagnosis of DILE.

Sections du résumé

BACKGROUND BACKGROUND
Drug-induced lupus erythematosus (DILE) is the development of lupus-like syndrome following a drug exposure. DILE has been reported less frequently among children than adults.
METHODS METHODS
In this study, we present four children with DILE and similar published cases through a systematic literature review.
RESULTS RESULTS
We report four children (three girls and one boy) who developed DILE associated with the use of topiramate, doxycycline, etanercept, and ethosuximide. Three of them were positive for anti-histone antibodies. In all patients, the drug was discontinued and symptoms resolved completely. The literature review revealed 48 articles describing 61 children with DILE. In the evaluation of 65 patients (our 4 patients and 61 patients from the literature), the most frequently reported drugs associated with DILE were ethosuximide (
CONCLUSION CONCLUSIONS
For children presenting with SLE features, proper drug history is crucial since DILE may be more frequent than anticipated. An association of the relevant drug with the symptoms, and resolution of symptoms on drug withdrawal provides evidence for the diagnosis of DILE.

Identifiants

pubmed: 38580326
doi: 10.1177/09612033241245078
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9612033241245078

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Ummusen Kaya Akca (U)

Department of Pediatrics, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.

Seher Sener (S)

Department of Pediatrics, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.

Ezgi Deniz Batu (ED)

Department of Pediatrics, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.

Zeynep Balik (Z)

Department of Pediatrics, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.

Ozge Basaran (O)

Department of Pediatrics, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.

Yelda Bilginer (Y)

Department of Pediatrics, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.

Seza Ozen (S)

Department of Pediatrics, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.

Classifications MeSH